WallStreetZen

NYSE: PFE
Pfizer Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PFE past earnings growth

How has PFE's earnings growth performed historically?
Company
-46.58%
Industry
12.96%
Market
38.12%
PFE's earnings have grown slower (2.78% per year) than the US Drug Manufacturers - General industry average (6.06%)
Performance
PFE's earnings have grown slower (2.78% per year) than the US market average (28.28%)
Performance
PFE's earnings growth is slowing down - its growth over the last year (-46.58%) is below its 5-year compound annual rate (2.78%)
Performance

PFE past revenue growth

How has PFE's revenue growth performed historically?
Company
-8.28%
Industry
9.05%
Market
15.77%
PFE's revenue has grown slower (0.3% per year) than the US Drug Manufacturers - General industry average (4.31%)
Performance
PFE's revenue has grown slower (0.3% per year) than the US market average (15.81%)
Performance
PFE's revenue growth is slowing down - its growth over the last year (-8.28%) is below its 5-year compound annual rate (0.3%)
Performance

PFE earnings and revenue history

Current Revenue
$48.6B
Current Earnings
$8.7B
Current Profit Margin
17.9%
PFE's has demonstrated consistent long-term earnings growth over the past 10 years (113.7%)
Performance

PFE Return on equity

Current Company
13.5%
Current Industry
55.3%
Current Market
23.9%
PFE's Return on Equity (13.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

PFE Return on assets

Current Company
5%
Current Industry
8.6%
Current Market
6.2%
PFE is generating lower Return on Assets (5%) than the US Drug Manufacturers - General industry average (8.21%)
Performance

PFE Return on capital employed

Current Company
5.85%
Current Industry
12.8%
PFE's ability to generate Return on Capital (5.85%) has decreased compared to 3 years ago (8.41%)
Performance

PFE earnings dates

Next earnings date
Feb 2, 2021

Pfizer Earnings & Revenue FAQ

What were PFE's earnings last quarter?

On Oct 27, 2020, Pfizer (NYSE: PFE) reported Q3 2020 earnings per share (EPS) of $0.39, up 71.74% year over year. Total Pfizer earnings for the quarter were $2.19 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $1.38.

What was PFE's revenue last quarter?

On Oct 27, 2020, Pfizer (NYSE: PFE) reported Q3 2020 revenue of $12.13 billion up 4.33% year over year. In the same quarter last year, Pfizer's revenue was $12.68 billion.

What was PFE's earnings growth in the past year?

As of Q1 2021, Pfizer's earnings has grown -46.58% year over year. This is 59.54 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 12.96%. Pfizer's earnings in the past year totalled $8.69 billion.

What was PFE's revenue growth in the past year?

As of Q1 2021, Pfizer's revenue has grown -8.28% year over year. This is 17.33 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 9.05%. Pfizer's revenue in the past year totalled $48.65 billion.

What is PFE's earnings date?

Pfizer's earnings date is Feb 02, 2021. Add PFE to your watchlist to be reminded of PFE's next earnings announcement.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics